Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue Suppl 3
631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform
Online download statistics by month:
Online download statistics by month: November 2020 to September 2024
Abstract
Full
Pdf
Nov 2020
209
0
33
Dec 2020
24
0
8
Jan 2021
38
0
3
Feb 2021
35
0
10
Mar 2021
68
0
12
Apr 2021
46
0
10
May 2021
10
0
10
Jun 2021
0
0
16
Jul 2021
0
0
10
Aug 2021
0
0
10
Sep 2021
0
0
12
Oct 2021
44
0
31
Nov 2021
36
0
30
Dec 2021
44
0
9
Jan 2022
52
0
21
Feb 2022
21
0
8
Mar 2022
54
0
7
Apr 2022
48
0
16
May 2022
28
0
14
Jun 2022
34
0
8
Jul 2022
37
0
5
Aug 2022
41
0
8
Sep 2022
14
0
3
Oct 2022
33
0
1
Nov 2022
20
0
4
Dec 2022
24
0
1
Jan 2023
20
0
0
Feb 2023
26
0
5
Mar 2023
24
0
3
Apr 2023
24
0
7
May 2023
22
0
5
Jun 2023
26
0
11
Jul 2023
20
0
3
Aug 2023
16
0
2
Sep 2023
16
0
2
Oct 2023
14
0
3
Nov 2023
30
0
5
Dec 2023
62
0
4
Jan 2024
4
0
0
Feb 2024
22
0
1
Mar 2024
44
0
4
Apr 2024
16
0
2
May 2024
16
0
1
Jun 2024
26
0
2
Jul 2024
38
0
2
Aug 2024
26
0
4
Sep 2024
26
0
3
Total
1478
0
369
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?